July 2010

With fewer PCPs, patients seek services from anyone, and that could raise utilization and costs
The head of the Midwest Business Group on Health says insurers must pick up where PPACA left off
Immunizations are a good deal for public health, but their growing number and rising costs pose a challenge for plans that must pay doctors for administering them
The Patient Protection and Affordable Care Act provides new initiatives to fight crooks and opportunists
The use of a single-pill combination of amlodipine/valsartan resulted in higher acquisition costs but fewer clinic visits, laboratory tests, and electrocardiograms — and therefore lower gross costs — compared with the use of individual drug component.


The law provides for premium reviews, but insurers say they’re afraid they’ll be hit with expensive challenges when efficiency is key
It might seem to be straight out of science fiction, but there’s solid science and engineering behind it
Blue Cross & Blue Shield of Oklahoma puts the emphasis on outcomes, rather than processes, and sweetens the pot with bonuses